Severe acute respiratory syndrome

Study: Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies. Image Credit: Lightspring / Shutterstock

Discovery of antibodies that may eliminate the need for COVID vaccines

In a recent study published in the journal Communication biologyresearchers evaluated the efficacy of monoclonal antibodies (mAb) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent donors infected with the Wuhan-1 strain against SARS-CoV-2 VOCs (variants of interest) such as Alpha, Beta, Gamma, Delta and Omicron. Study: Conformational flexibility in neutralization of SARS-CoV-2 by naturally …

Discovery of antibodies that may eliminate the need for COVID vaccines Read More »

Study: Promising natural products against SARS-CoV-2: Structure, function, and clinical trials. Image Credit: Olga Larionova/Shutterstock

A review of natural products with promising potential against SARS-CoV-2

In a recent review published in Phytotherapy researchresearchers reviewed the existing literature on naturally active products with therapeutic efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Promising natural products against SARS-CoV-2: Structure, function and clinical studies. Image credit: Olga Larionova/Shutterstock Studies have reported breakthrough infections with coronavirus disease 2019 (COVID-19) and multiple mutations …

A review of natural products with promising potential against SARS-CoV-2 Read More »

Study: Dynamics of Competing SARS-Cov-2 Variants During the Omicron Epidemic in England. Image Credit: Mayboon / Shutterstock.com

Additional SARS-CoV-2 variants and sporadic epidemics may become the ‘new normal’

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the coronavirus disease 2019 (COVID-19) pandemic, which has so far claimed more than 6.4 million deaths. Despite rigorous efforts to contain the transmission of the virus, SARS-CoV-2 spread rapidly and mutated several times. This led to the emergence of new variants of SARS-CoV-2 …

Additional SARS-CoV-2 variants and sporadic epidemics may become the ‘new normal’ Read More »

Study: Sex-Differences in COVID-19 Diagnosis, Risk Factors and Disease Comorbidities. Image Credit: Kzenon/Shutterstock

Study reveals disparities in clinical outcomes of COVID-19 in the US based on gender

In a recent study published on Research Square* Preprint server, Researchers examined gender differences among patients with coronavirus disease 2019 (COVID-19) in the United States (US). Study: Gender differences in the diagnosis of COVID-19, risk factors and disease comorbidities. Image credit: Kzenon/Shutterstock Studies report greater severity and mortality related to COVID-19 in men compared to …

Study reveals disparities in clinical outcomes of COVID-19 in the US based on gender Read More »

The effect of corticosteroids on mortality in hospitalized patients with COVID-19

In a recent study published on medRxiv* prepress server, researchers evaluated the impact of modern causal inference methods in estimating the effect of corticosteroids on coronavirus disease-related mortality 2019 (COVID-19). Study: Corticosteroids in COVID-19: Optimization of observational research through target trial emulations. Image credit: luchschenF / Shutterstock Observational research has provided great opportunities to understand …

The effect of corticosteroids on mortality in hospitalized patients with COVID-19 Read More »

Efficacy of nirmatrelvirus therapy in preventing COVID-19 mortality and hospitalizations in high-risk patients during Omicron growth

At the end of 2021, there was a worldwide recovery of coronavirus disease 2019 (COVID-19) due to the occurrence of highly transmissible acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron. Omicron surpassed the Delta variant by the end of December 2021. At the beginning of January, Omicron spread considerably around the world, even in places …

Efficacy of nirmatrelvirus therapy in preventing COVID-19 mortality and hospitalizations in high-risk patients during Omicron growth Read More »